ADIL Stock Summary and Trading Ideas (Adial Pharmaceuticals | NASDAQ:ADIL)

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Adial Pharmaceuticals trades on the NASDAQ stock market under the symbol ADIL.

As of October 2, 2026, ADIL stock price declined to $4.12 with 64,056 million shares trading.

ADIL has a beta of 1.89, meaning it tends to be more sensitive to market movements. ADIL has a correlation of 0.04 to the broad based SPY ETF.

ADIL has a market cap of $12.09 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ADIL traded as high as $104.25 and as low as $1.31.

The top ETF exchange traded funds that ADIL belongs to (by Net Assets): VXF.

ADIL has underperformed the market in the last year with a price return of -59.0% while the SPY ETF gained +16.1%. However, in the short term, ADIL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +42.1% vs +3.6% return in SPY. But in the last 2 weeks, ADIL shares have been beat by the market, returning -15.2% compared to an SPY return of +1.0%.

ADIL support price is $3.81 and resistance is $4.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADIL shares will trade within this expected range on the day.